Claim news

Johnson & Johnson in US$297 million settlement with Texas over opioid-related claims

Johnson & Johnson and its US-based Janssen Pharmaceutical Companies have announced a settlement agreement with the State of Texas and its participating subdivisions resolving their opioid-related claims against the company. Johnson & Johnson said that with this agreement, the company is removed from the pending Texas state and subdivision litigation, including two bellwether trials scheduled for early 2022.